Detalhe da pesquisa
1.
Integrating antibody drug conjugates in the management of gynecologic cancers.
Int J Gynecol Cancer
; 33(3): 420-429, 2023 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878560
2.
A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer.
Int J Gynecol Cancer
; 33(9): 1458-1463, 2023 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37666539
3.
Incidence of venous thromboembolism among patients receiving neoadjuvant chemotherapy for advanced epithelial ovarian cancer.
Int J Gynecol Cancer
; 30(4): 491-497, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32054646